Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 207
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00391755 | A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches | ||
| NCT02443922 | Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM | ||
| NCT01663207 | Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes | ||
| NCT00830869 | A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies | ||
| NCT00932698 | Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma | ||
| NCT05479721 | LITMUS Imaging Study | ||
| NCT03449030 | A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) | ||
| NCT02122770 | Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | ||
| NCT03535740 | A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib | ||
| NCT00853307 | MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma | ||
| NCT00500903 | A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors | ||
| NCT03501069 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants | ||
| NCT00722137 | Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma | ||
| NCT03783416 | SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis | ||
| NCT03106597 | Manidipine Versus Amlodipine in Patients With Hypertension | ||
| NCT01425008 | Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma | ||
| NCT02038647 | Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) | ||
| NCT03268941 | A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG) | ||
| NCT01167543 | Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease | ||
| NCT03748953 | Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT) | ||
| NCT01931566 | Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset | ||
| NCT01714947 | Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib | ||
| NCT01096290 | Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications | ||
| NCT02202759 | A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction | ||
| NCT01577758 | Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C | ||
| NCT00642694 | Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon | ||
| NCT03708211 | A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors | ||
| NCT01939899 | Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma | ||
| NCT01383928 | Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma | ||
| NCT07123350 | Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease | ||
| NCT00662363 | Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation | ||
| NCT01091428 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | ||
| NCT01328392 | Evaluating Treatment Response in Laryngo-Pharyngeal Reflux | ||
| NCT01156597 | Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes | ||
| NCT01454076 | Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma | ||
| NCT01023620 | HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) | ||
| NCT02202785 | A Study of MLN0264 in Patients With Pancreatic Cancer | ||
| NCT01799850 | The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle | ||
| NCT04056455 | A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys | ||
| NCT03057366 | A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors | ||
| NCT03477903 | TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI) | ||
| NCT03261947 | A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors | ||
| NCT02246647 | Biomarkers for Intestinal Permeability in Patients With Constipation | ||
| NCT01085643 | Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) | ||
| NCT02346344 | Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus | ||
| NCT03330106 | A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors | ||
| NCT01536457 | Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only | ||
| NCT01578499 | A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) | ||
| NCT01469819 | Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation | ||
| NCT02627677 | A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia |
